Supernus Pharmaceuticals, Inc. - Common Stock (NQ:SUPN)
Price and Volume
Detailed Quote| Volume | 562,991 |
| Open | 41.93 |
| Bid (Size) | 40.94 (200) |
| Ask (Size) | 41.05 (200) |
| Prev. Close | 42.01 |
| Today's Range | 40.60 - 43.26 |
| 52wk Range | 40.51 - 59.68 |
| Shares Outstanding | 53,145,884 |
| Dividend Yield | N/A |
Top News
More News
Performance
52-Week Range
31.3% below 52-week high
40.99
40.5152W Low
59.6852W High
1 Week
5.6% below 1-week high
41.131W Low
43.411W High
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN) traded between $40.51 and $59.68 over the past 52 weeks and last traded at $40.99, 31.3% below its 52-week high. Over the past week it ranged between $41.13 and $43.41.
Past 12 Months
1W
-$2.05
1M
-$0.50
3M
-$5.66
6M
-$9.12
YTD
-$8.48
1Y
-$7.39
SUPN was -15.3% over the past year, -18.2% over six months, -17.1% year to date, -4.8% in the last week.
12 Months vs Market
SUPN
-15.3%
DIA
+11.8%
SPY
+16.0%
QQQ
+21.2%
IWM
+11.0%
Over the past 12 months SUPN returned -15.3% versus DIA (Dow) +11.8%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +21.2% and IWM (Russell 2000) +11.0%.
Volume & Liquidity
0.74× 3-mo avg
Today 562,991
3-mo avg 760.4K
1W
802.1K
1M
731.9K
3M
760.4K
6M
763.8K
YTD
746.5K
1Y
762.3K
SUPN most recently traded 562,991 shares against a 3-month average daily volume of 760.4K.
More News
Read More
1 Unprofitable Stock with Impressive Fundamentals and 2 We Avoid
September 30, 2026
2 Growth Stocks to Add to Your Roster and 1 We Question
September 28, 2026
3 Reasons SUPN is Risky and 1 Stock to Buy Instead
September 21, 2026
3 Cash-Heavy Stocks Walking a Fine Line
September 16, 2026
Supernus Pharmaceuticals to Participate in September Investor Conferences
September 02, 2026
3 Out-of-Favor Stocks We’re Skeptical Of
September 02, 2026
3 Small-Cap Stocks with Open Questions
August 25, 2026
1 Healthcare Stock with Exciting Potential and 2 We Ignore
August 18, 2026
3 Russell 2000 Stocks We Approach with Caution
August 14, 2026
Why Supernus Pharmaceuticals Stock Topped the Market Today ↗
August 03, 2026
Supernus Pharmaceuticals Q2 Earnings Call Highlights ↗
August 03, 2026
What's going on in today's pre-market session ↗
August 03, 2026
Supernus Announces Second Quarter 2026 Financial Results
August 03, 2026
Frequently Asked Questions
Is Supernus Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Supernus Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Supernus Pharmaceuticals, Inc. - Common Stock trade on?
Supernus Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Supernus Pharmaceuticals, Inc. - Common Stock is SUPN on the Nasdaq Stock Market
What is the current price of Supernus Pharmaceuticals, Inc. - Common Stock?
The current price of Supernus Pharmaceuticals, Inc. - Common Stock is 40.99
When was Supernus Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Supernus Pharmaceuticals, Inc. - Common Stock was at 10/14/26 03:32 PM ET
What is the market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Supernus Pharmaceuticals, Inc. - Common Stock is 2.18B
How many shares of Supernus Pharmaceuticals, Inc. - Common Stock are outstanding?
Supernus Pharmaceuticals, Inc. - Common Stock has 2B shares outstanding.